The Ensign Group (NASDAQ:ENSG) Announces Earnings Results

Posted by George Bondi on Oct 28th, 2026

The Ensign Group (NASDAQ:ENSG – Get Free Report) released its quarterly earnings results on Tuesday. The company reported $2.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.97 by $0.06, FiscalAI reports. The firm had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.51 billion. During the same quarter in the prior year, the firm earned $1.64 earnings per share. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year.

The Ensign Group Stock Up 8.1%

ENSG opened at $183.21 on Wednesday. The firm has a market cap of $10.68 billion, a PE ratio of 28.72 and a beta of 0.66. The business has a fifty day simple moving average of $174.65 and a 200-day simple moving average of $181.46. The Ensign Group has a fifty-two week low of $141.58 and a fifty-two week high of $218.00.

The Ensign Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Saturday, October 31st. Investors of record on Wednesday, September 30th will be issued a dividend of $0.0650 per share. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date is Wednesday, September 30th. The Ensign Group’s dividend payout ratio (DPR) is presently 4.08%.

Key The Ensign Group News

Here are the key news stories impacting The Ensign Group this week:

Positive Sentiment: 2026 earnings guidance was raised. Ensign increased its full-year earnings outlook, signaling confidence in operating trends and supporting expectations for continued earnings growth. UBS analyst A.J. Rice reiterated a Buy rating following the update. The Ensign Group Raises Earnings Guidance for 2026 UBS Reiterates Buy on Ensign
Positive Sentiment: Third-quarter EPS beat expectations. Ensign reported earnings of $2.03 per share, above the $1.94–$1.97 consensus range and up from $1.64 a year earlier. Revenue rose 14.5% year over year to $1.48 billion, demonstrating continued growth in the business. Ensign Reports Third-Quarter 2026 Results
Neutral Sentiment: Revenue fell short of estimates. Although sales increased substantially year over year, the $1.48 billion result was below the approximately $1.51 billion analyst forecast, creating a mixed quarterly performance. Ensign Reports Sales Below Estimates
Negative Sentiment: Legal and reputational risks are pressuring the stock. Multiple law firms announced securities-fraud class actions or investor notices after a short-seller report alleged patient neglect, understaffing, manipulated quality and staffing data, improper billing, and an administrator-license rental scheme. These allegations have not been established in court, but the reports contributed to a sharp decline in ENSG shares and may increase litigation and regulatory uncertainty. The lead-plaintiff deadline is December 7, 2026. Ensign Securities-Fraud Lawsuit Alert

Analyst Ratings Changes

A number of equities research analysts recently commented on ENSG shares. Truist Financial boosted their target price on The Ensign Group from $202.00 to $207.00 and gave the stock a “hold” rating in a research report on Thursday, July 30th. Weiss Ratings upgraded The Ensign Group from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Royal Bank Of Canada reiterated an “outperform” rating and set a $228.00 target price on shares of The Ensign Group in a research report on Tuesday, July 28th. Finally, Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a report on Sunday. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $216.25.

View Our Latest Research Report on The Ensign Group

The Ensign Group Company Profile

(Get Free Report)

The Ensign Group, Inc is a healthcare services company that provides skilled nursing, post-acute care and rehabilitation services. Its facilities serve patients recovering from illness, injury or surgery, as well as individuals requiring long-term nursing care and support with daily living.

Through its operating subsidiaries, Ensign also provides assisted living and other senior care services. Its portfolio includes skilled nursing facilities, senior living communities and related healthcare operations, with services such as physical, occupational and speech therapy, medically complex care and rehabilitation.

Founded in 1999 and headquartered in San Juan Capistrano, California, The Ensign Group operates healthcare facilities across multiple U.S.